Cargando…

Contemporary issues for protecting patients in cancer research : workshop summary /

"In the nearly 40 years since implementation of federal regulations governing the protection of human participants in research, the number of clinical studies has grown exponentially. These studies have become more complex, with multisite trials now common, and there is increasing use of archiv...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: Contemporary Issues in Human Subjects Protections (Workshop) Washington, D.C.)
Otros Autores: Nass, Sharyl J. (rapporteur.), Patlak, Margie (rapporteur.)
Formato: Electrónico Congresos, conferencias eBook
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press, [2014]
Colección:Online access: National Academy of Sciences National Academies Press.
Online access: NCBI NCBI Bookshelf.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 EBOOKCENTRAL_ocn883575949
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cnu---unuuu
008 140708s2014 dcua ob 100 0 eng d
040 |a COO  |b eng  |e rda  |e pn  |c COO  |d MMU  |d CUS  |d N$T  |d YDXCP  |d OCLCF  |d OCL  |d OCLCO  |d OCLCQ  |d OCLCO  |d EBLCP  |d OCLCQ  |d OCLCO  |d VT2  |d DEBBG  |d AGLDB  |d ZCU  |d MERUC  |d NJR  |d OCLCO  |d MERER  |d OCLCO  |d OCLCA  |d BUF  |d OCLCO  |d OCLCQ  |d OCLCO  |d VNS  |d OCLCO  |d OCLCQ  |d VTS  |d ICG  |d OCLCO  |d AU@  |d REC  |d OCLCQ  |d LVT  |d STF  |d DKC  |d OCLCO  |d OCLCQ  |d M8D  |d OCLCO  |d OCL  |d OCLCO  |d OCLCQ  |d OCLCA  |d UKAHL  |d OCLCQ  |d OCLCA  |d OCLCO  |d OCLCA  |d OCLCO  |d OCLCQ  |d OCL  |d OCLCO  |d OCLCL  |d OCLCQ 
019 |a 1229742258 
020 |a 9780309306676  |q (electronic bk.) 
020 |a 0309306671  |q (electronic bk.) 
020 |z 9780309306669  |q (paperback) 
020 |z 0309306663  |q (paperback) 
029 1 |a DEBBG  |b BV042796295 
029 1 |a DEBBG  |b BV044185169 
029 1 |a DEBSZ  |b 446476013 
035 |a (OCoLC)883575949  |z (OCoLC)1229742258 
043 |a n-us--- 
050 4 |a R853.H8  |b C66 2014 
060 4 |a W 20.55.H9 
072 7 |a BUS  |x 008000  |2 bisacsh 
082 0 4 |a 174.28  |b 23 
049 |a UAMI 
111 2 |a Contemporary Issues in Human Subjects Protections (Workshop)  |d (2014 :  |c Washington, D.C.),  |j author. 
245 1 0 |a Contemporary issues for protecting patients in cancer research :  |b workshop summary /  |c Sharyl J. Nass and Margie Patlak, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies. 
246 3 0 |a Protecting patients in cancer research 
264 1 |a Washington, D.C. :  |b National Academies Press,  |c [2014] 
264 4 |c ©2014 
300 |a 1 online resource (xvii, 74 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a "In the nearly 40 years since implementation of federal regulations governing the protection of human participants in research, the number of clinical studies has grown exponentially. These studies have become more complex, with multisite trials now common, and there is increasing use of archived biospecimens and related data, including genomics data. In addition, growing emphasis on targeted cancer therapies requires greater collaboration and sharing of research data to ensure that rare patient subsets are adequately represented. Electronic records enable more extensive data collection and mining, but also raise concerns about the potential for inappropriate or unauthorized use of data, bringing patient protections into a new landscape. There are also long-standing concerns about the processes and forms used to obtain informed consent from patients participating in clinical studies. These changes and challenges raise new ethical and practical questions for the oversight of clinical studies, and for protecting patients and their health information in an efficient manner that does not compromise the progress of biomedical research. Contemporary Issues for Protecting Patients in Cancer Research is the summary of a workshop convened by the National Cancer Policy Forum of the Institute of Medicine in February 2014 to explore contemporary issues in human subjects protections as they pertain to cancer research, with the goal of identifying potential relevant policy actions. Clinical researchers, government officials, members of Institutional Review Boards, and patient advocates met to discuss clinical cancer research and oversight. This report examines current regulatory provisions that may not adequately protect patients or may be hindering research, and discusses potential strategies and actions to address those challenges"--Publisher's description. 
588 0 |a Online resource; title from resource home page (National Academies Press, viewed September 23, 2014). 
504 |a Includes bibliographical references. 
505 0 |a Introduction -- Current regulatory arena -- Common rule and HIPAA -- Shortcomings of current regulations and guidances -- Context -- Data deindentification -- Impediment to quality improvement and learning -- Varied interpretation -- Misaligned incentives -- Lack of harmonization with international standards -- Informed consent forms -- Informed consent process -- Consent tools -- Beyond consent -- HITECH -- Advanced notice of proposed rulemaking -- Patient perspectives on research protections -- Ethical challenges of genetic advances -- Patient consent for use of archived biospecimens -- Return of research results -- Clinically actionable findings -- Context matters -- Who pays -- Biospecimens from deceased participants -- The changing context of research and care -- Oversight in a learning health care system -- Oversight of pragmatic trials -- Multisite studies and IRB review -- Central IRBs -- New England Reliance Agreement -- Value of local IRBs -- Educational needs -- Research needs -- Wrap-up. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Human experimentation in medicine  |z United States  |v Congresses. 
650 0 |a Human experimentation in medicine  |x Moral and ethical aspects  |z United States  |v Congresses. 
650 0 |a Patients  |x Civil rights  |z United States  |v Congresses. 
650 0 |a Clinical trials  |z United States  |v Congresses. 
650 0 |a Cancer  |x Research  |z United States  |v Congresses. 
650 0 |a Medical ethics  |z United States  |v Congresses. 
650 0 |a Informed consent (Medical law) 
650 0 |a Institutional review boards (Medicine) 
650 1 2 |a Clinical Trials as Topic  |x standards 
650 1 2 |a Human Experimentation  |x standards  |z United States  |v Congresses. 
650 2 2 |a Patient Rights  |z United States  |v Congresses. 
650 2 2 |a Neoplasms  |z United States  |v Congresses. 
650 2 2 |a Ethics, Research  |z United States  |v Congresses. 
650 2 2 |a Ethics Committees, Research  |z United States  |v Congresses. 
650 2 2 |a Informed Consent  |z United States  |v Congresses. 
650 2 2 |a Research Subjects  |z United States  |v Congresses. 
650 2 2 |a Confidentiality  |x standards  |z United States  |v Congresses. 
650 2 2 |a Electronic Health Records  |x standards  |z United States  |v Congresses. 
650 2 2 |a Privacy  |z United States  |v Congresses. 
650 2 2 |a Researcher-Subject Relations  |z United States  |v Congresses. 
650 1 2 |a Clinical Trials as Topic  |x standards  |z United States  |v Congresses. 
650 2 2 |a Researcher-Subject Relations 
650 2 2 |a Informed Consent 
650 2 2 |a Ethics Committees, Research 
650 2 2 |a Confidentiality  |x standards 
650 2 2 |a Electronic Health Records  |x standards 
650 2 2 |a Privacy 
650 2 2 |a Patient Rights 
650 2 2 |a Neoplasms 
650 2 2 |a Ethics, Research 
650 1 2 |a Human Experimentation  |x standards 
650 2 2 |a Research Subjects 
651 2 |a United States 
650 2 |a Truth Disclosure 
650 6 |a Expérimentation humaine en médecine  |z États-Unis  |v Congrès. 
650 6 |a Expérimentation humaine en médecine  |x Aspect moral  |z États-Unis  |v Congrès. 
650 6 |a Patients  |x Droits  |z États-Unis  |v Congrès. 
650 6 |a Études cliniques  |z États-Unis  |v Congrès. 
650 6 |a Cancer  |x Recherche  |z États-Unis  |v Congrès. 
650 6 |a Éthique médicale  |z États-Unis  |v Congrès. 
650 6 |a Consentement éclairé (Droit médical) 
650 6 |a Comités d'éthique de la recherche. 
650 7 |a BUSINESS & ECONOMICS  |x Business Ethics.  |2 bisacsh 
650 7 |a Institutional review boards (Medicine)  |2 fast 
650 7 |a Informed consent (Medical law)  |2 fast 
650 7 |a Cancer  |x Research  |2 fast 
650 7 |a Clinical trials  |2 fast 
650 7 |a Human experimentation in medicine  |2 fast 
650 7 |a Human experimentation in medicine  |x Moral and ethical aspects  |2 fast 
650 7 |a Medical ethics  |2 fast 
650 7 |a Patients  |x Civil rights  |2 fast 
651 7 |a United States  |2 fast  |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq 
655 2 |a Congress 
655 7 |a proceedings (reports)  |2 aat 
655 7 |a Conference papers and proceedings  |2 fast 
655 7 |a Conference papers and proceedings.  |2 lcgft 
655 7 |a Actes de congrès.  |2 rvmgf 
700 1 |a Nass, Sharyl J.,  |e rapporteur. 
700 1 |a Patlak, Margie,  |e rapporteur. 
710 2 |a National Cancer Policy Forum (U.S.),  |e issuing body. 
758 |i has work:  |a Contemporary issues for protecting patients in cancer research (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCGKGx7HbkRPTvdB68TRkDq  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Erscheint auch als:  |n Druck-Ausgabe  |a Institute of Medicine (U.S.). Contemporary issues for protecting patients in cancer research .  |t Workshop summary 
830 0 |a Online access: National Academy of Sciences National Academies Press. 
830 0 |a Online access: NCBI NCBI Bookshelf. 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3379386  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36564273 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36617964 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL3379386 
938 |a EBSCOhost  |b EBSC  |n 867638 
938 |a YBP Library Services  |b YANK  |n 12112208 
994 |a 92  |b IZTAP